Please login to the form below
Actavis
The Top Pharma List rankings are compiled from GlobalData's
pharmaceutical revenue figures, which are based on prescription medicine
sales, including generics drugs.
Teva wins FDA OK for crucial migraine drug
order to pay down a very high level of debt stemming from its $39bn acquisition of Allergan’s generics business Actavis in 2015.
Axovant poaches Allergan’s and Teva’s chief medical and science officers
Most recently, Corcoran served as chief medical officer at Allergan and before that he was Actavis’ chief medical officer.
Morning brief: Roche raises outlook for 2018, ASCO abstracts revealed and more
The $64bn sum makes the deal the biggest pharma M&A transaction since Actavis bought Allergan in 2015 for $70.5bn.
Shire warms to Takeda’s latest offer, extending deadline
Analysts suggest however that negative sentiment could still scupper a deal that is by far the largest ever undertaken by the company - and the biggest in pharma since the $70bn
Shire rebuffs Takeda bids, as Allergan bows out
Allergan - also headquartered in Ireland - is no stranger to the M&A game having been bulked up by serial acquisitions in recent years, including a $66bn merger with Actavis in 2014
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
-
Senior Medical Writer
-
Salary TBC
-
Midweight Brand Planner
-
Up to £50, 000
- Head of Partnerships - Competitive - London
-
Competitive Salary Offered
Subscribe to our email news alerts
- Still no breakthrough on Orkambi talks, MPs want answers
- Curiosity – did it ever really kill the cat?
- Amgen buys Danish partner Nuevolution for $167m
- 90TEN named Best Agency in Continental Europe at PRWeek Global Awards
- Latecomer Lilly preps its IL-23 drug for Crohn’s disease
- Merck bulks up in cancer with $2.2bn Peloton buy
PMHub
Real Science Communications
Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...
Latest intelligence
- The Exhibition Hall: Past, Present and Future
- As I sit here at another pharma conference, I start to reflect on how they have changed over the years....
- Success breeds success
- This week we received the exciting news that we have been shortlisted for the Times Business Awards 2019, Tunbridge Wells in the 'Best Business 1-25 Employees' category....
- Turning learning into action: The challenge of behaviour change
- ...
Quick links
Infographics
